LAB vs OKE · rev $174.4M vs P/E 15, rev $21.70B
Standard Biotools Inc (LAB) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
LAB currently screens at market cap $317.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the LAB and OKE stock pages for the full models.
Not investment advice.